节点文献

盐酸恩丹西酮预防化疗所致呕吐Ⅱ期临床研究

Effect of ondansetron in the prevention of vomiting induced by chemotherapy: a phase Ⅱ study

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 傅小玉邓华邦于丁范玉华柯玉华胡艳萍周运华肖志华杨玲凌智君

【Author】 Fu Xiaoyu Deng Huabang Yu Ding, et al.Department of Chemotherapy, Hubei Cancer Hospital, Wuhan 430070

【机构】 湖北省肿瘤医院化疗科

【摘要】 目的:观察国产5-HT3阻滞剂-盐酸恩丹西酮预防化疗所致呕吐的临床疗效。方法:采用随机自身交替对照方法分为两组观察,接受顺铂联合化疗组及非顺铂联合化疗组各25例。盐酸恩丹西酮8mg,化疗前15分钟静注,恩丹西酮8mg,化疗后8小时口服。对照组:胃复安20mg,化疗前15分钟肌注,胃复安8mg化疗后8小时口服。结果:盐酸恩丹西酮对控制急性呕吐的有效率为96.0%,胃复安68.0%,其中CR分别为84.0%和46.0%(P<0.001)。结论:国产盐酸恩丹西酮对化疗所致呕吐具有良好的止吐效果,副作用小,且无锥体外系症状。

【Abstract】 Purpose: To evaluate the effect of ondansetron in prevention of vomiting caused by cancer chemotherapy. Method: This study was the radomized, cross-over study. The dose of PDD was 75~80 mg/m2, ADR was 25~50 mg/m2, 25 case with PDD, 25 case with non-PDD. Results: The rates of control-free of vomiting were 96.0% and 68.0% in ondansetron and maxolon respectively. The rates of CR were 84.0% and 46.0% repectively (P<0.001) at 24 hours. Conclusion: Ondansetron is efficacy on controting acute chemotherapy-induced vomiting in patients receiving PDD and non-PDD, and side effects were mild.

  • 【文献出处】 癌症 ,CHINESE JOURNAL OF CANCER , 编辑部邮箱 ,1998年03期
  • 【分类号】R730.53
  • 【被引频次】7
  • 【下载频次】21
节点文献中: 

本文链接的文献网络图示:

本文的引文网络